A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care
Jan Sørensen Artikkel Engelsk
*0011432722 *008070608s2007 xx# 000 0 eng *019 $bk *08230$a362.25 *100 $aSørensen, Jan$_141075500 *245 $aA Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care *300 $aS. [100]-108 *500 $aVitenskapelig artikkel *650 $aDepresjon$2norart$_12395700 *650 $aantidepressiver$9nor$2norart$_128837800 *651 $aDanmark$_10389400 *653 $aDenmark$9eng$_129552500 *653 $acitalopram$9eng$_159830800 *653 $acost-effectiveness$9eng$_136386100 *653 $aescitalopram$9eng$_131464500 *653 $amajor depressive disorder$9eng$_128838300 *653 $avenlafaxine$9eng$_141828500 *700 $aDamsbo, Niels$_158441800 *700 $aHemels, Michiel E.H.$_142678500 *700 $aLay, Agathe le$_160504600 *700 $aStage, Kurt Bjerregaard;$_160504700 *773 $tNordic journal of psychiatry$gVol. 61, no. 2 (2007)$x0803-9488$w(NO-LaBS)36505(tnr) *8564 $uhttps://doi.org/10.1080/08039480701226070 *999 $z700409250$anorart:700409250 ^